Name: Classifications and prognosis of myelodysplastic syndromes (en Inglés)
Price: 1139.12 MXN
Availability: InStock
Author: El Borgi, Wijden ; Boughzala, Rania
ISBN: 9786206194620

Envío gratis

portada Classifications and prognosis of myelodysplastic syndromes (en Inglés)

Formato

Libro Físico

Autor

Wijden El Borgi

Rania Boughzala

Editorial

Our Knowledge Publishing

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 0.3 cm

Peso

0.10 kg.

ISBN13

9786206194620

Categorías

Cuestiones generales de la medicina

Classifications and prognosis of myelodysplastic syndromes (en Inglés)

Wijden El Borgi (Autor) · Rania Boughzala (Autor) · Our Knowledge Publishing · Tapa Blanda

Libro Nuevo

$ 1,139.12

$ 2,071.12

Ahorras: $ 932.01

45% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Miércoles 31 de Julio y el Jueves 08 de Agosto.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Classifications and prognosis of myelodysplastic syndromes (en Inglés)"

Myelodysplastic syndromes (MDS) form a heterogeneous group of clonal hemopathies that are on the increase due to an aging population. Study objective: to establish the FAB and WHO 2008 classifications, IPSS and WPSS prognostic scores of 85 MDS diagnosed at our center over a 5-year period. The mean age of patients was 63.8 years. Anemia was present in 85% of patients. Dysplasia of the 3 erythroblastic, granular and megakaryocytic lineages was found in 75%, 85% and 68% of cases respectively. Cytogenetic abnormalities were present in 33% of cases, with 5q- abnormalities predominating. Refractory anemias and refractory cytopenias with multilineage dysplasia were most frequently observed. Low- and intermediate-risk groups1 according to the IPSS and low- and high-risk groups according to the WPSS were the most represented. Median survival was significantly different between prognostic groups. Transformation to acute myeloid leukemia occurred in 32% of cases. The risk of transformation was significantly different between MDS prognostic groups.